Showing 1 to 3 of 3 results


Huntington's Disease Progression Slowed by 75% in Clinical Trial
British researchers announced a 75% reduction in Huntington's disease progression over 36 months in a clinical trial of 29 patients using a new gene therapy, AMT-130, developed with UniQure.
Huntington's Disease Progression Slowed by 75% in Clinical Trial
British researchers announced a 75% reduction in Huntington's disease progression over 36 months in a clinical trial of 29 patients using a new gene therapy, AMT-130, developed with UniQure.
Progress
16% Bias Score


JAMA Study Finds No Evidence of Mystery Brain Disease in New Brunswick
A new peer-reviewed study published in JAMA found no evidence of a mystery brain disease in New Brunswick, Canada, concluding instead that 25 cases reviewed involved misdiagnosis of common neurodegenerative diseases; the province plans its own investigation of 222 cases.
JAMA Study Finds No Evidence of Mystery Brain Disease in New Brunswick
A new peer-reviewed study published in JAMA found no evidence of a mystery brain disease in New Brunswick, Canada, concluding instead that 25 cases reviewed involved misdiagnosis of common neurodegenerative diseases; the province plans its own investigation of 222 cases.
Progress
44% Bias Score

Study Debunks 'Mystery Illness' in New Brunswick
A new study in JAMA Neurology concludes that 25 patients in New Brunswick, initially believed to have a mysterious neurological illness, actually suffered from well-known conditions; researchers found that all patients had identifiable conditions such as Alzheimer's, Parkinson's, cancer, traumatic b...

Study Debunks 'Mystery Illness' in New Brunswick
A new study in JAMA Neurology concludes that 25 patients in New Brunswick, initially believed to have a mysterious neurological illness, actually suffered from well-known conditions; researchers found that all patients had identifiable conditions such as Alzheimer's, Parkinson's, cancer, traumatic b...
Progress
52% Bias Score
Showing 1 to 3 of 3 results